The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 29, 2014

Filed:

Apr. 29, 2011
Applicants:

Hans Kaspar Binz, Birmensdorf, CH;

Patrik Forrer, Dietikon, CH;

Michael Tobias Stumpp, Geroldswil, CH;

Inventors:

Hans Kaspar Binz, Birmensdorf, CH;

Patrik Forrer, Dietikon, CH;

Michael Tobias Stumpp, Geroldswil, CH;

Assignee:

Molecular Partners AG, Schlieren, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); C07K 17/08 (2006.01); C07K 14/00 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
A61K 38/16 (2013.01); C07K 14/00 (2013.01); A61K 47/48215 (2013.01); C07K 17/08 (2013.01);
Abstract

The present invention relates to binding proteins specific for Vascular Endothelial Growth Factor A (VEGF-A), in particular to recombinant binding proteins comprising a polyethylene glycol moiety and a binding domain, which inhibits VEGF-Axxx (wherein xxx denotes the amino acid length of the VEGF-A mature protein) binding to Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2). Examples of such recombinant binding proteins are proteins which comprise an ankyrin repeat domain with the desired binding specificity, and a polyethylene glycol moiety. The binding proteins are useful in the treatment of cancer and other pathological conditions, e.g. eye diseases such as age-related macular degeneration.


Find Patent Forward Citations

Loading…